Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5289404
Max Phase: Preclinical
Molecular Formula: C15H10N6OS
Molecular Weight: 322.35
Associated Items:
ID: ALA5289404
Max Phase: Preclinical
Molecular Formula: C15H10N6OS
Molecular Weight: 322.35
Associated Items:
Canonical SMILES: N#CC(C#N)=C1SC(n2nc(O)cc2N)=CN1c1ccccc1
Standard InChI: InChI=1S/C15H10N6OS/c16-7-10(8-17)15-20(11-4-2-1-3-5-11)9-14(23-15)21-12(18)6-13(22)19-21/h1-6,9H,18H2,(H,19,22)
Standard InChI Key: UBRAFIABPGDNPA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 322.35 | Molecular Weight (Monoisotopic): 322.0637 | AlogP: 2.44 | #Rotatable Bonds: 2 |
Polar Surface Area: 114.89 | Molecular Species: ACID | HBA: 8 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 5.76 | CX Basic pKa: 1.88 | CX LogP: 3.04 | CX LogD: 1.62 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.82 | Np Likeness Score: -1.09 |
1. Sharma PC, Bansal KK, Sharma A, Sharma D, Deep A.. (2020) Thiazole-containing compounds as therapeutic targets for cancer therapy., 188 [PMID:31926469] [10.1016/j.ejmech.2019.112016] |
Source(1):